LifeMD (LFMD) Q2 Revenue Rises 23%

LifeMD (NASDAQ:LFMD), a telehealth platform specializing in virtual care and digital health subscriptions, reported its second quarter 2025 financial results on August 5, 2025. Revenue (GAAP) was $62.2 million, up 23% from the same period last year but $4.1 million below consensus estimates (GAAP). Earnings per share (EPS) came in at a loss of $0.06 (GAAP), which was also below analyst expectations by $0.0517 (GAAP). Despite year-over-year expansion in core business metrics, results missed both revenue and GAAP earnings projections. The quarter showcased strong telehealth growth and improved operational profitability, but also included a guidance reduction for the full year, pointing to segment-specific pressures, especially within men’s health. Overall, the period highlighted robust subscriber and adjusted EBITDA gains alongside mounting challenges in forecasting and segment execution. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. LifeMD delivers virtual healthcare services directly to consumers in all 50 states, focusing on subscription-based telehealth for chronic condition management, primary care, and specialty health segments. It operates two main businesses: a telehealth segment delivering care through a vertically integrated platform (including pharmacy and labs), and WorkSimpli, a smaller software platform targeting administrative business solutions.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool